RG
ABBV icon

Rikoon Group’s AbbVie ABBV Stock Holding History

Rikoon Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$10.5M Buy
97,466
+160
+0.2% +$17.1K 2.81% 6
2020
Q4 		$10.4M Sell
97,306
-1,264
-1% -$121K 2.91% 6
2020
Q3 		$8.63M Buy
98,570
+19
+0% +$1.79K 2.67% 7
2020
Q2 		$9.68M Buy
98,551
+2,488
+3% +$219K 3.23% 6
2020
Q1 		$7.32M Sell
96,063
-60
-0.1% -$5.11K 3.03% 5
2019
Q4 		$8.51M Buy
96,123
+3,532
+4% +$293K 2.93% 4
2019
Q3 		$7.01M Sell
92,591
-601
-0.6% -$41.2K 2.6% 4
2019
Q2 		$6.78M Buy
93,192
+24
+0% +$1.89K 2.52% 5
2019
Q1 		$7.51M Sell
93,168
-936
-1% -$76.6K 2.79% 5
2018
Q4 		$8.68M Sell
94,104
-1,149
-1% -$101K 3.59% 3
2018
Q3 		$9.01M Buy
95,253
+6
+0% +$569 3.19% 4
2018
Q2 		$8.82M Buy
95,247
+335
+0.4% +$32.7K 3.37% 3
2018
Q1 		$8.68M Buy
94,912
+3,162
+3% +$347K 3.52% 3
2017
Q4 		$8.87M Sell
91,750
-200
-0.2% -$18.8K 3.67% 3
2017
Q3 		$8.17M Sell
91,950
-345
-0.4% -$26.3K 3.54% 3
2017
Q2 		$6.69M Sell
92,295
-100
-0.1% -$6.72K 2.97% 5
2017
Q1 		$6.09M Sell
92,395
-25
-0% -$1.57K 2.69% 5
2016
Q4 		$5.58M Buy
92,420
+77,742
+530% +$4.75M 2.46% 6
2016
Q3 		$925K Buy
+14,678
New +$950K 0.73% 48

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Rikoon Group's ABBV Position: Q1 2021 in Review

Rikoon Group increased its AbbVie (ABBV) stake by 0.16% in Q1 2021, buying an estimated $17.1K and bringing the position to 97,466 shares worth $10.5M. The position accounts for 2.81% of the portfolio, ranked #6.

Rikoon Group first reported a position in ABBV in Q3 2016 and has held it in 19 quarters since. 2,615 funds tracked by Wall St. Rank hold ABBV as of Q1 2021.

  • Rikoon Group held 97,466 shares of AbbVie worth $10.5M as of Q1 2021.
  • Rikoon Group bought 160 AbbVie shares in Q1 2021, an estimated $17.1K.
  • AbbVie made up 2.81% of Rikoon Group's portfolio in Q1 2021, its #6 holding.
  • Rikoon Group first reported a position in AbbVie in Q3 2016 and has held it in 19 quarters since.
  • 2,615 funds tracked by Wall St. Rank held AbbVie as of Q1 2021.

Based on Rikoon Group's 13F filing for Q1 2021, filed 14 May 2021.